Adam Boros, PhD
Adam studied at the University of Toronto, Faculty of Medicine for his MSc and PhD conducting research on the immune system throughout pregnancy. He has worked as a medical pharmaceutical writer and was involved in both the promotional and educational aspects of drug development. When Adam isn’t writing, you can find him playing jazz piano or cooking something adventurous in the kitchen.
Articles by Adam Boros, PhD
| 5 min read
After tackling toxicity and a trial halt, Elena Koundourakis and her team at Takeda are on the cusp of a first-in-class drug for people living with narcolepsy.
| 4 min read
Elizabeth Laws leads Sanofi’s inflammation and immunology development pipeline to test the first oral TNFR1 inhibitor for rheumatoid arthritis and psoriasis.
| 3 min read
Engineered platelets controlled bleeding in mice and pig models of trauma.
| 4 min read
Merck researchers developed an effective vaccine against pneumococcal diseases.
| 3 min read
Cowpea mosaic virus stimulated the immune system to treat and prevent metastatic cancers in mice.
| 4 min read
Targeted drug delivery using microneedle patches could help treat alopecia areata.
| 3 min read
A changing dance of transcription factors modulates T regulatory cell gene expression in different immune contexts with implications for cancer and autoimmune diseases.
| 3 min read
Manish Sharma led a clinical trial for a new antibody-drug conjugate that decreased tumor size in patients who had not responded to chemotherapy.
| 3 min read
Organ-on-a-chip technology can replicate the cervix microenvironment in bacterial vaginosis.
| 3 min read
Epilepsy onset and seizure severity are linked to variants in the SCN2A gene, potentially leading to improved diagnostics and treatments.
| 3 min read
Natural killer cells can sometimes attack beneficial CAR T cell immunotherapies. Now, researchers have discovered why and a potential way to stop them.
| 4 min read
Researchers uncovered the structure of the measles fusion glycoprotein and identified a neutralizing antibody capable of decreasing its virulence.
| 3 min read
Placental macrophages play a role in the immune response against pathogens.
| 3 min read
Specialized cells in omental adipose tissue may repress fat cell development.
| 5 min read
Jeremy Gale leads Pfizer’s inflammation & immunology research program to develop new therapies for moderate to severe inflammatory bowel disease.
Page 1 of 2 - 24 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Harnessing liver-on-a-chip models for drug safety
Discover how researchers leverage microphysiological systems in toxicology studies.
Enhancing bioanalytical studies with centralized data management
Learn how researchers can improve compliance and efficiency with advanced LIMS solutions.
Explained: How are metabolite biomarkers improving drug discovery and development?
By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
